Breaking News: FSD Pharma Signs Binding LOI to Acquire Therapix Biosciences (NASDAQ: TRPX)

Breaking News: FSD Pharma Signs Binding LOI to Acquire Therapix Biosciences (NASDAQ: TRPX – RICH TV LIVE – October 22, 2018 – FSD Pharma Signs Binding LOI to Acquire Therapix Biosciences, a NASDAQ Traded Pharmaceutical Company Focusing on the Development of Cannabinoid-Based Treatments, to Create Medical Cannabis Industry Innovator

Hey guys how you doing this is your boy rich here on behalf of rich tv live we have some breaking news huge news fsd pharma signs binding loi to acquire therapist biosciences a nasdaq traded pharmaceutical company focused on the development of cannabinoid based treatments to create medical cannabis industry innovator look at this unbelievable news it is exploding

Post market they are acquiring a $4 and 42 cent nasdaq company and the stock has exploded post market it is up to $7 up 58% on this huge breaking news and you’re hearing it first from here from your boy rich transaction combines two highly complementary businesses the significant production and distribution of medical and recreational products by fsd pharma and

The premium and differentiated medical and pharmaceutical brands by therapists biosciences brings together highly competent scientific and business leadership teams to execute upon a shared vision to deliver proprietary cannabinoid platform technologies to both professional and retail markets globally transaction strategic partner part of fsd pharma’s interest to

Pursue access to international capital markets to attract high-quality high-profile financial and strategic investors to participate in accelerating company growth plans and establishing a strong position in cannabinoid research space space i’m so excited i can’t even speak transaction focuses on therap x proprietary ip and related technology and assets pertaining

See also  COVID-19 CORONAVIRUS OUTBREAK 1775 DEATHS 71334 INFECTED

To all clinical stage pharmaceutical assets applications therapist biosciences shareholders to receive 48 million usd of farm fsd pharma stock the transaction is subject to the shareholder approval of both parties and further subject to additional preconditions required to be met prior to the closing the transaction no later than 3 months following the execution

Of a definitive agreement wow i can’t believe this it is up eighty-one percent oh my goodness it is exploding as we speak up $3.58 on this news what is huge gonna do on this huge news unbelievable hu ge in canada f s dd f in america ok9 in frankfurt announced today the signing of a binding letter of intent loi to acquire a therapist biosciences limited unbelievable

This combines two highly complementary businesses and creates a medical cannabis industry innovator focused on the research and development of advanced cannabinoid treatments fsd farm is gonna explode tomorrow thera picks bioscience the shareholders will receive 48 million usd of fst stock upon closing we talked about this the transaction is structured at a fixed

Price of 48 million usd 60 2.4 million canadian representing approximately 130 million class b subordinates shares of fsd pharma and nearly 10 percent of the company today the final number of class b subordinates shares and percentage ownership of the company will fluctuate based on the 20-day averages of fsd pharma stock closing price on the date the transaction is

Finalized the transaction is arm’s length and no finders fees have been paid it is anticipated that the common shares of the company will continue to be listed on the canadian securities exchange cse and frankfurt stock exchange and the company tends to apply the list on the nasdaq subject to regulatory approvals wow whoo congratulations to everyone holding huge

See also  Mobile application| Finance Tube | Vishal Thakkar

The terms of the loi will be superseded by a definitive agreement with fsd pharma and therapists intend to execute within 30 days oh my goodness the intended acquisition of therap experinces biosciences at this time is a pivotal step in the evolution of our company by entering the high-value medical cannabis market in addition to growing products for the direct to

Consumer retail cannabis market in canada we are now developing a new class of novel cannabinoid based treatments for several central nervous system disorders including chronic pain fibrin yel jia irritable bowel syndrome and several other disease areas with this acquisition fst pharma is signaling our commitment to furthering very high value from a suitable rnd

Clinical programs centered on cannabinoid molecules a number of which are actively underway at several distinguished medical institutions across the globe including among others the therapists investigator-initiated phase two a study at yale university medical center in the us for tourette’s syndrome program oh my goodness this is such big news the prepare the

Preparations for commencing anticipated subsequent phase 2b studies at the hanover and munich university medical school’s in germany for tourette syndrome program and collaboration with as suta medical centers in israel to develop the therapeutic products in the field of sleeping disorders our strategy also involves pursuing access to the international capital

Markets to attract high-quality high-profile financial and strategic investors in the space who can participate in and assist with the accelerating our growth plans and establishing a strong position in this area this is such big news breaking news what do you think about this news if you like this news please smash the like button comment down below share the

See also  I Sold 9,000+ of LB Stock

Video everywhere remember if you’re winning and i’m winning we’re all winning empathy pharma science binding loi to acquire therapists biosciences a nasdaq trainmen pharmaceutical company focused on the development of cannabinoid based treatments to create medical cannabis industry innovator while the stock is up 9% now at $9.25 aftermarket this is crazy news the

Stock is exploding and i’m looking at huge what is huge doing aftermarket it’s not showing what huge is doing aftermarket this is insane it is still climbing now up 119 percent oh my goodness now remember wrist eagle i be strictly for education entertainment purposes do your due diligence do your research before investing anything we talked about here enriched if

You live up a hundred twenty six percent now on the news at nine dollars and ninety nine cents this is your boy rich if you’re not winning you’re not watching mo piece it just broke ten dollars

Transcribed from video
Breaking News: FSD Pharma Signs Binding LOI to Acquire Therapix Biosciences (NASDAQ: TRPX) By RICH TV LIVE

Scroll to top